- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
Hong Kong Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Dec 11, 2023
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
98 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 1643Modern Chinese Medicine Group | HK$0.34 | -1.4% | -46.0% | HK$204.0m | n/a | PE2.9x | n/a | 0% | ||
| 503Lansen Pharmaceutical Holdings | HK$1.79 | 0% | 25.2% | HK$750.6m | n/a | PE13x | n/a | 2.7% | ||
| 6978Immunotech Biopharm | HK$4.01 | 0% | -21.7% | HK$2.1b | n/a | PB4.9x | n/a | n/a | ||
| 1672Ascletis Pharma | HK$1.77 | -1.1% | -52.5% | HK$1.9b | HK$2.81 | PS27.3x | E7.9% | n/a | ||
| 6118Austar Lifesciences | HK$1.84 | -0.5% | -21.0% | HK$943.2m | n/a | PE517.5x | n/a | 0% | ||
| 9926Akeso | HK$45.40 | -3.9% | 8.0% | HK$38.2b | HK$55.09 | PE17.7x | E-25.3% | n/a | ||
| 12443D Medicines | HK$8.48 | -6.2% | n/a | HK$2.2b | n/a | PS2.8x | n/a | n/a | ||
| 3681SinoMab BioScience | HK$1.68 | 28.2% | -6.7% | HK$1.7b | n/a | PS316.6x | n/a | n/a | ||
| 1312Kontafarma China Holdings | HK$0.034 | -2.9% | -12.8% | HK$190.0m | n/a | PE35.1x | n/a | 0% | ||
| 1011China NT Pharma Group | HK$0.071 | -1.4% | -35.5% | HK$187.5m | n/a | PS1x | n/a | 0% | ||
| 775CK Life Sciences Int'l. (Holdings) | HK$0.62 | -1.6% | -24.4% | HK$6.0b | n/a | PE57.4x | n/a | 1.3% | ||
| 897Wai Yuen Tong Medicine Holdings | HK$0.38 | -2.6% | 15.2% | HK$445.0m | n/a | PE12.2x | n/a | 0% | ||
| 455Tianda Pharmaceuticals | HK$0.22 | 1.9% | -30.5% | HK$470.9m | n/a | PB0.7x | n/a | 1.2% | ||
| 8225China Health Group | HK$0.15 | 16.7% | -47.8% | HK$153.3m | n/a | PS7.9x | n/a | n/a | ||
| 690Uni-Bio Science Group | HK$0.05 | 16.3% | 0% | HK$318.2m | n/a | PE5x | n/a | n/a | ||
| 8329Shenzhen Neptunus Interlong Bio-technique | HK$0.15 | 1.4% | -13.5% | HK$246.7m | n/a | PE3.5x | n/a | n/a | ||
| 8247Biosino Bio-Technology and Science Incorporation | HK$0.86 | 2.4% | -34.8% | HK$124.4m | n/a | PB0.6x | n/a | 0% | ||
| 3737Zhongzhi Pharmaceutical Holdings | HK$1.43 | -2.7% | 27.7% | HK$1.2b | n/a | PE6.9x | n/a | 8.3% | ||
| 2105Laekna | HK$14.96 | -13.5% | n/a | HK$5.8b | n/a | PS13170.9x | n/a | n/a | ||
| 239Pak Fah Yeow International | HK$1.61 | -10.1% | 36.4% | HK$517.3m | n/a | PE5.7x | n/a | 7.6% | ||
| 1349Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd | HK$2.45 | -0.8% | -22.5% | HK$8.5b | n/a | PE12.2x | n/a | 3.2% | ||
| 8158China Regenerative Medicine International | HK$0.51 | 45.7% | -60.2% | HK$145.6m | n/a | PE215x | n/a | n/a | ||
| 2348Dawnrays Pharmaceutical (Holdings) | HK$1.03 | -1.0% | -20.2% | HK$1.5b | n/a | PE3.2x | n/a | 8.5% | ||
| 3933United Laboratories International Holdings | HK$6.93 | -10.3% | 37.0% | HK$12.6b | HK$10.66 | PE5.2x | E-0.9% | 5.0% |